AETHLON MEDICAL INC (AEMD)

US00808Y4061 - Common Stock

0.4334  -0.23 (-34.39%)

Premarket: 0.417 -0.02 (-3.78%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
660K
1.54%
290K
-56.06%
570K
96.55%

-100.00%
EBITDA
YoY % growth
-7.85M
-33.05%
-10.3M
-31.21%
-11.66M
-13.20%
N/A
-5.30%
N/AN/A
EBIT
YoY % growth
-7.89M
-33.05%
-10.42M
-32.07%
-11.9M
-14.20%
-13.661M
-6.19%
-12.278M
2.84%
-12.501M
-1.82%
Operating Margin
-1,195.45%-3,593.10%-2,087.72%N/AN/AN/A
EPS
YoY % growth
N/A
-125.02%
-4.49
36.81%
-5.90
-31.40%
-5.54
16.95%
-1.04
78.77%
-0.67
35.29%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.22
84.12%
-0.23
74.97%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
N/AN/A
EBIT
Q2Q % growth
-2.974M
16.64%
-3.075M
-23.69%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
-0.20
83.61%
-0.200.00-0.55%
Q1 2025
Q2Q % growth
-0.34
75.71%
-0.32-0.02-5.82%
Q4 2024
Q2Q % growth
-0.91
9.00%
-1.250.3427.47%
Q3 2024
Q2Q % growth
-1.37
-14.17%
-1.25-0.12-9.20%
Q2 2024
Q2Q % growth
-1.22
32.22%
-1.430.2114.57%
Q1 2024
Q2Q % growth
-1.40
26.32%
-1.33-0.07-5.58%
Q4 2023
Q2Q % growth
-1.00
61.54%
-1.330.3324.59%
Q3 2023
Q2Q % growth
-1.20
25.00%
-0.82-0.38-47.06%
Q2 2023
Q2Q % growth
-1.80
-1,284.62%
-2.190.3917.92%
Q1 2023
Q2Q % growth
-1.90
-1,087.50%
-2.240.3415.33%
Q4 2022
Q2Q % growth
-2.60
-1,633.33%
-1.43-1.17-82.07%
Q3 2022
Q2Q % growth
-1.60
-700.00%
-1.33-0.27-20.66%
Q2 2022
Q2Q % growth
-0.13
13.33%
-0.150.0215.03%
Q1 2022
Q2Q % growth
-0.16 -0.13-0.03-20.66%
Q4 2021
Q2Q % growth
-0.15
31.19%
-0.200.0525.23%
Q3 2021
Q2Q % growth
-0.20
33.33%
-0.17-0.03-18.84%
Q2 2021
Q2Q % growth
-0.15
88.37%
-0.12-0.03-22.55%
Q4 2020
Q2Q % growth
-0.22
83.85%
-0.16-0.05-33.58%
Q3 2020
Q2Q % growth
-0.30
81.82%
-1.050.7571.44%
Q2 2020
Q2Q % growth
-1.29
-7.50%
-1.12-0.17-14.97%
Q1 2020
Q2Q % growth
-1.35
-50.00%
-1.22-0.13-10.29%
Q4 2019
Q2Q % growth
-1.35
-50.00%
-1.07-0.28-26.05%
Q3 2019
Q2Q % growth
-1.65
-37.50%
-1.07-0.58-54.06%
Q2 2019
Q2Q % growth
-1.20 -1.07-0.13-12.04%
Q1 2019
Q2Q % growth
-0.90 -1.220.3226.47%
Q4 2018
Q2Q % growth
-0.90 -1.530.6341.18%
Q3 2018
Q2Q % growth
-1.20 -1.680.4828.70%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth

-100.00%
%
Q4 2023
Q2Q % growth
574.25K
5,642.50%
574.25K%
Q3 2023
Q2Q % growth

-100.00%
3.235M-3.235M-100.00%
Q2 2023
Q2Q % growth

-100.00%
70.89K-70.89K-100.00%
Q1 2023
Q2Q % growth

-100.00%
70.89K-70.89K-100.00%
Q4 2022
Q2Q % growth
10K
-66.67%
735.42K-725.42K-98.64%
Q3 2022
Q2Q % growth
20K
-96.77%
261.12K-241.12K-92.34%
Q2 2022
Q2Q % growth
130K 192.78K-62.78K-32.57%
Q1 2022
Q2Q % growth
130K 204K-74K-36.27%
Q4 2021
Q2Q % growth
30K
-85.71%
380.797K-350.797K-92.12%
Q3 2021
Q2Q % growth
620K
51.22%
102K518K507.84%
Q1 2021
Q2Q % growth

-100.00%
%
Q4 2020
Q2Q % growth
210K
162.50%
306K-96K-31.37%
Q3 2020
Q2Q % growth
410K 191.76K218.24K113.81%
Q2 2020
Q2Q % growth
191.76K-191.76K-100.00%
Q1 2020
Q2Q % growth
30K
-80.00%
30K%
Q4 2019
Q2Q % growth
80K
14.29%
51K29K56.86%
Q3 2019
Q2Q % growth

-100.00%
%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% 0%
RevenueN/A N/A N/A N/A